Vera Therapeutics, Inc.(VERA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VERA Vera Therapeutics, Inc.

已收盘 08-31 16:00:00 EDT

34.08

-0.11

-0.32%

盘后34.08

+0.000.00%

19:57 EDT

最高34.38	最低33.18	成交量153.67万
今开33.64	昨收34.19	日振幅3.51%
总市值24.44亿	流通市值21.40亿	总股本7,171万
成交额5,206万	换手率2.45%	流通股本6,280万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VERA","market":"US","secType":"STK","nameCN":"Vera Therapeutics, Inc.","latestPrice":34.08,"timestamp":1788206400000,"preClose":34.19,"halted":0,"volume":1536715,"hourTrading":{"tag":"盘后","latestPrice":34.08,"preClose":34.08,"latestTime":"19:57 EDT","volume":80018,"amount":2727055.817,"timestamp":1788220673772,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.003217315004387231,"floatShares":62802805,"shares":71713905,"eps":-5.898389,"marketStatus":"已收盘","change":-0.11,"latestTime":"08-31 16:00:00 EDT","open":33.64,"high":34.38,"low":33.18,"amount":52060640.21734,"amplitude":0.035098,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.898389,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"listingDate":1620964800000,"exchange":"NASDAQ","adjPreClose":34.19,"preHourTrading":{"tag":"盘前","latestPrice":33.92,"preClose":34.19,"latestTime":"09:27 EDT","volume":3408,"amount":116873.81568,"timestamp":1788182870061,"change":-0.27,"changeRate":-0.007897,"amplitude":0.037438},"postHourTrading":{"tag":"盘后","latestPrice":34.08,"preClose":34.08,"latestTime":"19:57 EDT","volume":80018,"amount":2727055.817,"timestamp":1788220673772,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.678905,"impliedVol":1.1021,"impliedVolPercentile":0.7928},"requestUrl":"/m/hq/s/VERA/tweets","defaultTab":"tweets","newsList":[{"id":"1148913190","title":"Vera Therapeutics任命Nancy Boman为首席监管官，William Turner计划退休","url":"https://stock-news.laohu8.com/highlight/detail?id=1148913190","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148913190?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:07","pubTimestamp":1783598876,"startTime":"0","endTime":"0","summary":"Vera Therapeutics, Inc. 宣布了其高级领导团队的重要人事变动。公司已任命Nancy Boman担任首席监管官一职，同时，William Turner宣布了其退休计划。Nancy Boman在生物制药领域的监管事务方面拥有深厚的专业知识和丰富的行业经验，她的加入预计将进一步加强公司在产品开发和合规方面的领导力。他在任期间为公司的发展做出了贡献，其离职安排将确保相关职责的平稳过渡。此次人事调整是Vera Therapeutics完善其管理架构的一部分，旨在支持公司未来的长期发展战略和管线推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA","BK4585","BK4539","BK4139","LU2324357040.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105188762","title":"Vera Therapeutics高管透露：Trutakna四剂或28天疗程批发采购价为32,700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105188762","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105188762?lang=zh_cn&edition=full","pubTime":"2026-07-08 04:46","pubTimestamp":1783457192,"startTime":"0","endTime":"0","summary":"Vera Therapeutics公司高管在电话会议中确认，其药物Trutakna的四剂或28天疗程批发采购成本设定为32,700美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA","BK4585","BK4539","BK4139","LU2324357040.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111378876","title":"Vera Therapeutics股价飙升：肾病新药获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1111378876","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111378876?lang=zh_cn&edition=full","pubTime":"2026-07-08 02:47","pubTimestamp":1783450047,"startTime":"0","endTime":"0","summary":"周二，Vera Therapeutics, Inc.的股价上涨约8%，此前美国食品药品监督管理局批准了其用于治疗IgA肾病的药物。这款名为Trutakna的药物通过阻断两种蛋白质来发挥作用，这两种蛋白质会促使免疫系统产生抗体，这些抗体在肾脏中积聚并造成损伤。这是美国首个获批同时靶向这两种蛋白质的药物，尽管已有其他几种药物治疗该疾病。福泰制药正在研发一种同样能阻断这两种蛋白质的类似药物，FDA预计将在今年晚些时候对此做出裁决。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU2417539215.USD","SG9999013999.USD","BK4567","LU1093756325.SGD","IE00B894F039.SGD","BBH","LU0061475181.USD","LU1035775433.USD","LU1093756168.USD","IE00B19Z9Z06.USD","LU0432979614.USD","SG9999001176.SGD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","LU1430594728.SGD","VRTX","LU2362540622.SGD","LU0079474960.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","LU0417517546.SGD","SGXZ57979304.SGD","IBBQ","LU1674673691.USD","LU2237438978.USD","LU1585245621.USD","LU2362541273.HKD","LU2236285917.USD","LU0823416689.USD","LU1069344957.HKD","LU0320765992.SGD","LU0289739699.SGD","IE00B19Z9P08.USD","LABU","SG9999001176.USD","LU2462157665.USD","IE00B4R5TH58.HKD","LU1674673428.USD","LU2362541513.USD","IE00BFTCPJ56.SGD","BK4139","IE0002270589.USD","LU1778281490.HKD","IE00BJT1NW94.SGD","IDNA","BK4539","IE00B19Z3B42.SGD","IE0009355771.USD","BK4532","VERA","LU2456880835.USD","IBB","BK4585","PBE","LU0109394709.USD","BIB","BK4588","IE00B19Z3581.USD","LU0234570918.USD","LU2324357040.USD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128788964","title":"Vera Therapeutics旗下Trutakna™获FDA加速批准用于治疗成人原发性IgA肾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1128788964","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128788964?lang=zh_cn&edition=full","pubTime":"2026-07-08 00:38","pubTimestamp":1783442318,"startTime":"0","endTime":"0","summary":"Vera Therapeutics公司宣布，其药物Trutakna™已获得美国食品药品监督管理局（FDA）的加速批准，用于治疗成人原发性免疫球蛋白A肾病（IgA肾病）。这一批准标志着该疾病治疗领域的一个重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","VERA","LU2324357040.USD","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197787046","title":"Vera Therapeutics与美国FDA就早期ORIGIN 3期分析达成一致，为atacicept在成人IgA肾病中的完全批准铺路","url":"https://stock-news.laohu8.com/highlight/detail?id=1197787046","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197787046?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:02","pubTimestamp":1780398123,"startTime":"0","endTime":"0","summary":"Vera Therapeutics, Inc. (VERA) 宣布，已与美国食品药品监督管理局 (FDA) 就针对成人IgA肾病患者的研究药物atacicept的ORIGIN 3期临床试验达成一致。双方同意将一项更早的中期分析纳入支持该药物潜在完全批准的计划中。这一共识旨在加速监管审评进程，为atacicept早日获得全面批准创造条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VERA","BK4139","LU2324357040.USD","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152935780","title":"Vera Therapeutics公布2026年一季度财务数据：现金及等价物与有价证券总额达5.968亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152935780","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152935780?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:39","pubTimestamp":1778153954,"startTime":"0","endTime":"0","summary":"截至2026年3月31日，生物制药公司Vera Therapeutics, Inc.持有的现金、现金等价物及有价证券总额达到5.968亿美元。这一财务数据彰显了公司在创新药物研发领域的资金实力，为其核心管线产品的临床推进提供了稳健的财务支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4539","BK4139","LU2324357040.USD","BK4588","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518207880","title":"Vera Therapeutics, Inc.盘中异动 下午盘股价大跌5.10%报27.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518207880?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:02","pubTimestamp":1741633362,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时02分，Vera Therapeutics, Inc.股票出现异动，股价大幅下跌5.10%。截至发稿，该股报27.35美元/股，成交量34.9152万股，换手率0.55%，振幅5.69%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6185.95%、3855.31%、1016.34%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103024298a2dc61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103024298a2dc61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERA","LENZ","BK4588","BK4585","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517592133","title":"Vera Therapeutics, Inc.盘中异动 股价大涨5.28%报30.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517592133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517592133?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:53","pubTimestamp":1741208002,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时53分，Vera Therapeutics, Inc.股票出现波动，股价快速拉升5.28%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为990.11%、322.79%、321.36%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为497.01%、82.59%、54.27%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045323abea1c37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045323abea1c37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERA","LENZ","BK4539","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516663454","title":"Vera Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516663454?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:44","pubTimestamp":1741034655,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时44分，Vera Therapeutics, Inc.股票出现波动，股价大幅跳水5.08%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4654.37%、216.36%、188.06%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044416a25da762&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044416a25da762&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4539","VERA","LENZ","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514382851","title":"Vera Therapeutics, Inc.盘中异动 早盘股价大涨5.08%报29.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514382851?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:02","pubTimestamp":1740672133,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时02分，Vera Therapeutics, Inc.股票出现异动，股价急速拉升5.08%。截至发稿，该股报29.18美元/股，成交量9.7414万股，换手率0.15%，振幅3.29%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Quoin Pharmaceuticals Ltd、Alpha Tau Medical Ltd C/Wts 、Pepgen Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1480.34%、246.33%、109.54%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Quoin Pharmaceuticals Ltd、Pds Biotechnology Corporation，振幅分别为86.14%、47.79%、45.45%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000213abdf8540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000213abdf8540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4588","LENZ","BK4539","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856036","title":"Vera Therapeutics, Inc.盘中异动 快速拉升5.06%报28.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856036?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580337,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Vera Therapeutics, Inc.股票出现波动，股价大幅拉升5.06%。截至发稿，该股报28.47美元/股，成交量1.2618万股，换手率0.02%，振幅2.10%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2818.09%、118.03%、90.31%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为35.59%、16.86%、14.35%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223217a254f69f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223217a254f69f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","VERA","BK4585","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153119985","title":"Vera Therapeutics 2024 财年 GAAP 每股收益 $(2.75) 超过 $(2.83) 预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1153119985","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153119985?lang=zh_cn&edition=full","pubTime":"2025-02-26 21:38","pubTimestamp":1740577116,"startTime":"0","endTime":"0","summary":"Vera Therapeutics报告季度每股亏损为 $，这比分析师一致预估的 $ 高出2.83%。与去年同期每股亏损 $ 相比，这一数字下降了22.22%。以上内容来自Benzinga Earnings专栏，原文如下：Vera $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 2.83 percent. This is a 22.22 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166077","title":"Vera Therapeutics, Inc.盘中异动 急速拉升6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166077?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889129,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Vera Therapeutics, Inc.股票出现异动，股价大幅拉升6.34%。截至发稿，该股报29.20美元/股，成交量3.05万股，换手率0.05%，振幅3.53%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为276.09%、91.01%、60.62%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.57%、8.35%、6.13%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232099889fca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232099889fca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","VERA","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511993146","title":"Vera Therapeutics, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511993146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511993146?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:50","pubTimestamp":1739544622,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时50分，Vera Therapeutics, Inc.股票出现波动，股价大幅下跌5.03%。截至发稿，该股报32.46美元/股，成交量5.2783万股，换手率0.08%，振幅5.56%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1914.86%、497.45%、427.85%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422502398858e62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422502398858e62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4539","BK4585","BK4139","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510338776","title":"Vera Therapeutics, Inc.盘中异动 股价大跌5.13%报34.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510338776?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:07","pubTimestamp":1739286435,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时07分，Vera Therapeutics, Inc.股票出现异动，股价大幅下跌5.13%。截至发稿，该股报34.04美元/股，成交量4.6683万股，换手率0.07%，振幅3.83%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.52%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2505.47%、744.73%、330.29%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为52.11%、39.80%、37.99%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211230715961f4eaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211230715961f4eaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4588","BK4585","LENZ","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507420621","title":"Vera Therapeutics, Inc.盘中异动 大幅上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507420621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507420621?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:35","pubTimestamp":1738247713,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时35分，Vera Therapeutics, Inc.股票出现波动，股价快速上涨5.30%。截至发稿，该股报39.94美元/股，成交量2.1831万股，换手率0.03%，振幅3.27%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Alterity Therapeutics Limited、Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为721.86%、129.52%、109.80%，振幅较大的相关个股有Kazia Therapeutics Limited、Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为28.25%、24.49%、21.31%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022351496143e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022351496143e15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","VERA","BK4588","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506514934","title":"Vera Therapeutics, Inc.盘中异动 早盘股价大涨6.72%报37.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506514934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506514934?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074707,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Vera Therapeutics, Inc.股票出现异动，股价快速上涨6.72%。截至发稿，该股报37.18美元/股，成交量2.7929万股，换手率0.04%，振幅1.80%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Transcode Therapeutics, Inc.涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1248.65%、574.10%、215.82%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Atyr Pharma, Inc.、Allarity Therapeutics, Inc.，振幅分别为111.38%、102.25%、101.97%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223147abbb65c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223147abbb65c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LENZ","BK4139","BK4539","BK4585","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503588403","title":"Vera Therapeutics, Inc.盘中异动 早盘股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503588403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503588403?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:30","pubTimestamp":1736778628,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时30分，Vera Therapeutics, Inc.股票出现波动，股价大幅下挫5.46%。截至发稿，该股报35.00美元/股，成交量1.0784万股，换手率0.02%，振幅0.00%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2471.71%、1557.00%、388.10%，振幅较大的相关个股有Regulus Therapeutics Inc.、Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.，振幅分别为8.51%、6.50%、6.39%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223029aba92ff6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223029aba92ff6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","BK4139","BK4588","BK4539","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502189527","title":"Vera Therapeutics, Inc.盘中异动 早盘大幅下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502189527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502189527?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:00","pubTimestamp":1736521216,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时00分，Vera Therapeutics, Inc.股票出现波动，股价急速跳水5.21%。截至发稿，该股报39.99美元/股，成交量2.7742万股，换手率0.04%，振幅3.22%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Moolec Science Sa C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1084.15%、273.32%、188.67%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为64.51%、41.78%、37.29%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230016aba60a2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230016aba60a2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","VERA","LENZ","BK4139","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493009425","title":"Vera Therapeutics, Inc.盘中异动 股价大涨5.15%报44.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493009425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493009425?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:08","pubTimestamp":1734710907,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时08分，Vera Therapeutics, Inc.股票出现异动，股价急速拉升5.15%。截至发稿，该股报44.22美元/股，成交量37.0749万股，换手率0.59%，振幅7.16%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221000827984cfe14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221000827984cfe14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VERA","BK4588","BK4139","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.veratx.com","stockEarnings":[{"period":"1week","weight":0.0593},{"period":"1month","weight":0.0517},{"period":"3month","weight":-0.0374},{"period":"6month","weight":-0.1618},{"period":"1year","weight":0.5339},{"period":"ytd","weight":-0.3248}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vera Therapeutics, Inc.最初于2016年5月在特拉华州注册成立，名称为CDF Therapeutics，Inc.，并于2020年4月更名为Vera Therapeutics, Inc.。该公司是一家处于临床后期阶段的生物技术公司，专注于为患有严重免疫疾病的患者开发和商业化转化疗法。该公司的主要候选产品atacicept是一种自我给药的融合蛋白，可阻断B淋巴细胞刺激物和增殖诱导配体，具有治疗IgA肾病的同类最佳潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.057587},{"month":2,"riseRate":0.4,"avgChangeRate":0.015839},{"month":3,"riseRate":0.4,"avgChangeRate":-0.047765},{"month":4,"riseRate":0,"avgChangeRate":-0.103447},{"month":5,"riseRate":0.2,"avgChangeRate":-0.049498},{"month":6,"riseRate":0.5,"avgChangeRate":0.171762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.072704},{"month":8,"riseRate":0.666667,"avgChangeRate":0.026778},{"month":9,"riseRate":0.6,"avgChangeRate":0.088867},{"month":10,"riseRate":0.2,"avgChangeRate":-0.071412},{"month":11,"riseRate":0.8,"avgChangeRate":0.292871},{"month":12,"riseRate":0.6,"avgChangeRate":0.07812}],"exchange":"NASDAQ","name":"Vera Therapeutics, Inc.","nameEN":"Vera Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vera Therapeutics, Inc.(VERA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vera Therapeutics, Inc.(VERA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vera Therapeutics, Inc.,VERA,Vera Therapeutics, Inc.股票,Vera Therapeutics, Inc.股票老虎,Vera Therapeutics, Inc.股票老虎国际,Vera Therapeutics, Inc.行情,Vera Therapeutics, Inc.股票行情,Vera Therapeutics, Inc.股价,Vera Therapeutics, Inc.股市,Vera Therapeutics, Inc.股票价格,Vera Therapeutics, Inc.股票交易,Vera Therapeutics, Inc.股票购买,Vera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vera Therapeutics, Inc.(VERA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vera Therapeutics, Inc.(VERA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}